Total Payments
$11,292
2024 Payments
$1,578
Companies
40
Transactions
385
Medicare Patients
20,825
Medicare Billing
$3.7M
Payment Breakdown by Category
Food & Beverage$11,000 (97.4%)
Education$291.81 (2.6%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $11,000 | 381 | 97.4% |
| Education | $291.81 | 4 | 2.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Abbott Laboratories | $1,301 | 15 | $0 (2023) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $1,187 | 32 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $1,084 | 89 | $0 (2024) |
| Amgen Inc. | $1,024 | 59 | $0 (2024) |
| Biosense Webster, Inc. | $706.52 | 6 | $0 (2020) |
| PFIZER INC. | $587.30 | 33 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $563.81 | 28 | $0 (2024) |
| Medtronic, Inc. | $491.63 | 3 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $402.43 | 13 | $0 (2024) |
| Novo Nordisk Inc | $347.79 | 8 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,578 | 56 | Novartis Pharmaceuticals Corporation ($295.08) |
| 2023 | $1,848 | 63 | Medtronic, Inc. ($318.66) |
| 2022 | $1,783 | 67 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) ($294.11) |
| 2021 | $882.98 | 34 | Inari Medical, Inc. ($329.00) |
| 2020 | $1,147 | 39 | Amgen Inc. ($257.72) |
| 2019 | $1,596 | 45 | Biosense Webster, Inc. ($479.29) |
| 2018 | $1,167 | 51 | AstraZeneca Pharmaceuticals LP ($174.40) |
| 2017 | $1,290 | 30 | BOSTON SCIENTIFIC CORPORATION ($281.61) |
All Payment Transactions
385 individual payment records from CMS Open Payments — Page 1 of 16
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/14/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $31.57 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/12/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $13.50 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 11/04/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $16.18 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 10/28/2024 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $24.25 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/12/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $23.89 | General |
| Category: Obesity | ||||||
| 09/10/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $44.52 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 08/27/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $146.12 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/21/2024 | Alnylam Pharmaceuticals Inc. | AMVUTTRA (Drug) | Food and Beverage | In-kind items and services | $17.17 | General |
| Category: Genetic Disease | ||||||
| 08/09/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $18.89 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/08/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $27.35 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 08/08/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $14.02 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 07/29/2024 | Medtronic, Inc. | MICRA (Device) | Food and Beverage | In-kind items and services | $172.97 | General |
| Category: Pacemakers | ||||||
| 07/29/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $20.52 | General |
| Category: Cardiovascular | ||||||
| 07/25/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $21.54 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 07/09/2024 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug), UPTRAVI | Food and Beverage | In-kind items and services | $24.93 | General |
| Category: Cardiology | ||||||
| 06/27/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $14.01 | General |
| Category: Diabetes | ||||||
| 06/13/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $26.59 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 06/11/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $19.06 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 06/10/2024 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $19.39 | General |
| Category: CARDIOVASCULAR | ||||||
| 06/07/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $3.95 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 05/17/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $22.50 | General |
| Category: DIABETES | ||||||
| 05/15/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $19.44 | General |
| Category: Cardiology | ||||||
| 05/14/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.53 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/14/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $6.13 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 05/13/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $17.26 | General |
| Category: Cardiology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 33 | 5,958 | 8,582 | $3.7M | $1.1M |
| 2022 | 34 | 5,400 | 8,396 | $3.1M | $978,077 |
| 2021 | 35 | 5,741 | 8,832 | $2.9M | $1.1M |
| 2020 | 32 | 3,726 | 5,634 | $1.6M | $566,979 |
Total Patients
20,825
Total Services
31,444
Medicare Billing
$3.7M
Procedure Codes
146
All Medicare Procedures & Services
146 procedure records from CMS Medicare Utilization — Page 1 of 6
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 78492 | Nuclear medicine studies of blood flow in heart muscle at rest and with stress | Office | 2023 | 192 | 192 | $671,616 | $208,974 | 31.1% |
| A9555 | Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | Office | 2023 | 194 | 378 | $461,916 | $152,793 | 33.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 657 | 1,290 | $404,517 | $118,697 | 29.3% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 357 | 1,074 | $315,028 | $97,198 | 30.9% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2023 | 698 | 701 | $329,362 | $95,888 | 29.1% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 649 | 658 | $317,156 | $88,932 | 28.0% |
| 93229 | Electrocardiogram (ecg) up to 30 days continuous with transmission of patient triggered events with review and report by health care professional | Office | 2023 | 83 | 85 | $173,775 | $53,711 | 30.9% |
| 93925 | Ultrasound of leg arteries or artery grafts | Office | 2023 | 267 | 272 | $160,405 | $48,498 | 30.2% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2023 | 248 | 944 | $144,493 | $42,815 | 29.6% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 214 | 222 | $94,273 | $28,658 | 30.4% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2023 | 86 | 86 | $92,356 | $28,150 | 30.5% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 486 | 496 | $82,856 | $25,044 | 30.2% |
| 93970 | Ultrasound study of arm or leg veins with compression and maneuvers | Office | 2023 | 158 | 160 | $74,080 | $21,307 | 28.8% |
| 93978 | Complete ultrasound of aorta, vena cava, groin vessels or bypass grafts | Office | 2023 | 168 | 169 | $74,845 | $19,705 | 26.3% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2023 | 284 | 284 | $49,356 | $14,185 | 28.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 100 | 100 | $40,970 | $11,689 | 28.5% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 513 | 629 | $22,626 | $6,544 | 28.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 87 | 95 | $21,070 | $6,056 | 28.7% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 40 | 40 | $12,840 | $3,838 | 29.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 39 | 43 | $10,320 | $3,157 | 30.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 31 | 31 | $10,168 | $3,081 | 30.3% |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | Office | 2023 | 82 | 160 | $45,760 | $2,772 | 6.1% |
| 93294 | Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | Office | 2023 | 42 | 91 | $6,734 | $2,092 | 31.1% |
| 93312 | Ultrasound of heart with probe in esophagus, with report | Facility | 2023 | 20 | 20 | $5,240 | $1,637 | 31.2% |
| 93298 | Evaluation of cardiac rhythm monitor system, remote up to 30 days | Office | 2023 | 13 | 74 | $4,810 | $1,449 | 30.1% |
About Dr. Pradeep Bhat, MD
Dr. Pradeep Bhat, MD is a Cardiovascular Disease healthcare provider based in Phoenix, Arizona. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/20/2007. The National Provider Identifier (NPI) number assigned to this provider is 1275729592.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Pradeep Bhat, MD has received a total of $11,292 in payments from pharmaceutical and medical device companies, with $1,578 received in 2024. These payments were reported across 385 transactions from 40 companies. The most common payment nature is "Food and Beverage" ($11,000).
As a Medicare-enrolled provider, Bhat has provided services to 20,825 Medicare beneficiaries, totaling 31,444 services with total Medicare billing of $3.7M. Data is available for 4 years (2020–2023), covering 146 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Location Phoenix, AZ
- Active Since 09/20/2007
- Last Updated 06/29/2022
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1275729592
Products in Payments
- LifeVest (Device) $1,187
- Repatha (Biological) $958.05
- Carto 3 System (Device) $706.52
- ENTRESTO (Drug) $634.76
- ELIQUIS (Drug) $593.25
- XARELTO (Drug) $563.81
- LEQVIO (Drug) $449.69
- BRILINTA (Drug) $379.59
- MICRA (Device) $339.49
- FLOWTRIEVER CATHETER, S (Device) $329.00
- Impella (Device) $284.64
- THE LATITUDE PATIENT MANAGEMENT SYSTEM (Device) $281.61
- OPTIMIZER (Device) $268.78
- CardioMEMS HF System (Device) $249.27
- CRT-Ds (Device) $212.41
- Cleerly Ischemia (Device) $180.33
- COREVALVE EVOLUT R (Device) $152.14
- Confirm Rx (Device) $150.08
- JETI (Device) $149.42
- JARDIANCE (Drug) $146.59
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Phoenix
Ashish Gupta, M.d, M.D
Cardiovascular Disease — Payments: $1.2M
Cardiovascular Disease $1.2M
Dr. Timothy Byrne, Do, DO
Cardiovascular Disease — Payments: $838,695
Cardiovascular Disease $838,695
Dr. J. Weiss, M.d, M.D
Cardiovascular Disease — Payments: $288,755
Cardiovascular Disease $288,755
Tabitha Moe, M.d, M.D
Cardiovascular Disease — Payments: $154,170
Cardiovascular Disease $154,170
Dr. Akil Loli, Md, MD
Cardiovascular Disease — Payments: $139,062
Cardiovascular Disease $139,062
Mark Seifert, Md, MD
Cardiovascular Disease — Payments: $132,833
Cardiovascular Disease $132,833